CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-28 | Greenstreet Yvonne Chief Executive Officer | Sale | −214 | $244.11 | $52K | 84,547 |
| 2025-02-28 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −42 | $236.51 | $10K | 34,652 |
| 2025-02-28 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −34 | $238.33 | $8K | 34,618 |
| 2025-02-28 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −35 | $239.18 | $8K | 34,583 |
| 2025-02-28 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −78 | $240.32 | $19K | 34,505 |
| 2025-02-28 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −127 | $241.51 | $31K | 34,378 |
| 2025-02-28 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −300 | $242.44 | $73K | 34,078 |
| 2025-02-28 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −121 | $243.23 | $29K | 33,957 |
| 2025-02-28 | Poulton Jeffrey V. EVP, Chief Financial Officer | Sale | −59 | $244.11 | $14K | 33,898 |
| 2025-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −28 | $236.51 | $7K | 14,830 |
| 2025-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −22 | $238.33 | $5K | 14,808 |
| 2025-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −23 | $239.18 | $6K | 14,785 |
| 2025-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −50 | $240.32 | $12K | 14,735 |
| 2025-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −82 | $241.51 | $20K | 14,653 |
| 2025-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −192 | $242.44 | $47K | 14,461 |
| 2025-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −78 | $243.23 | $19K | 14,383 |
| 2025-02-28 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −38 | $244.11 | $9K | 14,345 |
| 2025-02-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −51 | $236.51 | $12K | 13,846 |
| 2025-02-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −40 | $238.33 | $10K | 13,806 |
| 2025-02-28 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −41 | $239.18 | $10K | 13,765 |
Page 34 of 41 · 816 trades